TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Variation in bone marrow fat fraction (BMFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of confirmed episodes of late-onset sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Psychomotor development with the Griffiths III
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of clinically significant hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Global Impression Scale for AS (CGI-AS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hammersmith Neonatal Neurological Examination (HINE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Composite endpoint of patient death, graft loss, or eGFR < 45ml/min/1.73m2
Endpoint domain: Mortality/survival
Primary endpoint: Composite endpoint of patient death, graft loss, or eGFR < 45ml/min/1.73m2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Psychological health impact
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Severity of breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cumulative recovery of total radioactivity in urine or/and feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BNP (B-type Natriuretic Peptide)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Prescribers With Awareness of Updated Educational Materials
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Prescribers With Change in Knowledge and Understanding of Key Safety Information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Prescribers With Change in Self-Reported Behavior Prescribing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cortical perfusion measured by ASL-MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Renal microvascular blood flow measured by CEUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical symptoms of ADHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Showering behaviour concerning frequency
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Showering behaviour concerning duration
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Showering behaviour concerning motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of patients with complete healing/closure of the target ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Participants' Willingness to Enter the Trial
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Handgrip strength in Kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body composition using dual energy x-ray absorptiometry (DXA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body composition using body composition monitor (BCM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Free flap perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with modified Rankin Scale (mRS) score 0-1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Median Pain Scores in the Post-Anesthesia Care Unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative pain at 12-24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative Anesthesia Unit Length of Stay (hours)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of Participants with AEs of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Abnormal Pregnancies as SAE
Endpoint domain: Adverse events/effects
Primary endpoint: Re-intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quality of life before after procedure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under the serum concentration-time curve of insulin aspart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Economic Impact
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Health Care Utilization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Grade of adhesion between the surface of the heart/large vessels and surrounding tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak Torque Measurement 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak Torque Measurement 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak Torque Measurement 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak Torque Measurement 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak Torque Measurement 5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Oedema
Endpoint domain: Adverse events/effects
Primary endpoint: percentage fully immunization coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smoldering component of white matter lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in plasma TFV level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ADHD Rating Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease Activity Score28 (DAS28)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician global assessment (PhGA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of CR/CRi with negative MRD
Endpoint domain: Mortality/survival
Primary endpoint: Number of Non-Drinking Days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction of 50% or more on the mean 24-hour HF score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of organoids-on-chip for drug screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of organoids-on-chip for drug screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of organoids-on-chip for drug screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiometabolic disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Children's puberty development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child's fitness and motor skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV disclosure rate
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Marginal integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Dissociation state
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Procedural anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean length of stay of VLBWI
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Rate of compliance with adjuvant therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adult ADHD Self-Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adult ADHD Quality of Life Measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Feasibility of delivery by acute stroke NHS clinicians
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Contralateral breast cancer incidence
Endpoint domain: Mortality/survival
Primary endpoint: APACHE II score on Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of acquisition events and the number of non-acquisition of E-ESBL in newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of open orders for FIT screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of open orders for mammography screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of Participants with mRS Score Improvement ≥ 1
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ICL vault size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative UCVA and BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievements towards quitting smoking
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: bacteriologically confirmed pulmonary TB disease
Endpoint domain: Mortality/survival
Primary endpoint: Intracranial response rate (iORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: VAS Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in markers of liver toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in markers of kidney toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in markers of tumor lysis syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Pancreatic fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time up and go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child neurodevelopmental assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Time Curve (AUC) of Ramucirumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of Ramucirumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Trough Concentration (Ctrough) of Ramucirumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of secondary surgical interventions (SSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of other serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of ocular adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of subjective visual disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPECT/CT-based 99mTc-ADAPT6 uptake value in tumor lesions (SUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPECT/CT-based 99mTc-ADAPT6 uptake value in metastatic lymph nodes (SUV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LN-to-background LN ratio (SPECT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Caregiver Respite and Burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Expression of SGLT2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG measures during urination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic floor muscle (PFM) EEG measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of Areas of synchrony in EEG Patterns and associated Urodynamics (UDS) findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validation of virtual biopsy accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Early recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Post operative pain duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (AUC0-t, AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical Cancer Screening Uptakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in procalcitonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in respiratory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Pa/Fi ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Area Under the Concentration-Time Curve from 0 to Infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in objectively-assessed cardiorespiratory fitness (CRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in estimated cardiorespiratory fitness (CRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percent of wounds that have healed at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to return to previous function/resumption of normal activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ease of Use Subscale Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of Adverse Events (AE) after PRG-2311 infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Eosinophilic Cationic Protein (ECP) in Nasal Epithelial Lining Fluid (NELF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunoglobulin E (IgE) in Nasal Epithelial Lining Fluid (NELF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gastric food content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Frequency of Plasmodium falciparum mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Thickness of fibrous cap of coronary artery plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrent pneumothorax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Detection of miRNA-155
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stabilometry variables eyes open before pressure release COP area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stabilometry variables eyes closed after pressure release COP area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular, Peripheral Refractive Error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monocular, Photopic BCDVA at 4 M
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Events rates
Endpoint domain: Adverse events/effects
Primary endpoint: Children's State Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Utilization of evidence-based psychotherapies (EBPs) for PTSD
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Phe blood concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 30 dash test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Survival (PFS) at Month 36
Endpoint domain: Mortality/survival
Primary endpoint: Autism Awareness Scale of Mothers of Preschool Children
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Toilet Training
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Readiness to Stop Breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of maternal obstetric complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of degradation within three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reach of alcohol-related care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adoption of alcohol-related care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maintenance of alcohol-related care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of treatment procedure disruption
Endpoint domain: Adverse events/effects
Primary endpoint: Parathyroid transplant function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Calcium supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Steroid-free, combined clinical and biological remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New white spot lesions (WSLs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Severity of Alopecia Tool (SALT) Score at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Confocal Microscopy Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of Confocal Microscopy Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum diameter of balloon expelled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who develop ICU delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of PEG-asparaginase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Cigarettes Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: progression of axial length (AL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Reported Outcomes Measurement Information System - Sleep Related Impairment (PROMIS-SRI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Patient-Reported Outcomes Measurement Information System - Sleep Disturbance (PROMIS-SD)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Composite Sleep Health Score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: 2-point or greater drop in RASS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUVmax change in F18 Fluoride PET scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Tremor Phenomenology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Stimulation-Induced Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Stimulation-Induced Dysarthria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracranial complication ruling out
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PD1-lmyphocytes in bronchoalveolar lavage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean change from baseline score on Catherine Bergego Scale after 10 therapy sessions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean change from baseline score on Catherine Bergego Scale after 20 therapy sessions
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in vena cava inferior collapsibility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall response rate of the treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daycare diet of the children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in climate impact of Food System model at systemic level
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in food service cost of Food System model at systemic level
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Protein Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Complicated ascites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean blood pressure during daytime
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CT angiogram results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes